Five-year outcomes for frontline brentuximab vedotin with CHP for CD30-expressing peripheral T-cell lymphomas
This phase 1 study evaluated frontline brentuximab vedotin in combination with cyclophosphamide, doxorubicin, and prednisone …
This phase 1 study evaluated frontline brentuximab vedotin in combination with cyclophosphamide, doxorubicin, and prednisone …
In 2008, the International Workshop on Chronic Lymphocytic Leukemia (iwCLL) published consensus guidelines for the …
We studied adults with acute myeloid leukemia (AML) after haploidentical (n = 192) and 8/8 …
The recommendations include a revised version of the ELN genetic categories, a proposal for a …
Recent genetic analyses of large populations have revealed that somatic mutations in hematopoietic cells leading …
The concept that there are lymphoid proliferations that we used to diagnose as overt lymphoid …
The revisions to the categories of myeloid neoplasms and acute leukemia will be published in …
A 50-year-old African man with well-controlled HIV infection presented with constitutional symptoms, progressive multiorgan failure, …
The intrigue and danger of the disease is that the patient a long time does …
When necessary “turned on” to reverse the process. Insulin in turn is a waste product …